Stephen Willey
Stock Analyst at Stifel
(3.13)
# 1,089
Out of 4,479 analysts
75
Total ratings
39.47%
Success rate
2.24%
Average return
Main Sectors:
Top Industries:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GERN Geron | Maintains: Buy | $6 → $7 | $4.17 | +67.87% | 2 | Jun 10, 2024 | |
| INSM Insmed | Maintains: Buy | $67 → $74 | $64.50 | +14.73% | 2 | Jun 5, 2024 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $27 | $18.93 | +42.63% | 3 | May 15, 2024 | |
| BOLT Bolt Biotherapeutics | Downgrades: Hold | $6 → $1.5 | $0.74 | +104.08% | 2 | May 15, 2024 | |
| MGNX MacroGenics | Downgrades: Hold | $29 → $7 | $4.10 | +70.73% | 2 | May 10, 2024 | |
| MEIP MEI Pharma | Maintains: Hold | $7 | $2.80 | +150.00% | 5 | Apr 12, 2024 | |
| CUE Cue Biopharma | Maintains: Buy | $8 | $1.08 | +640.74% | 5 | Apr 9, 2024 | |
| VOR Vor Biopharma | Maintains: Buy | $15 → $12 | $0.91 | +1,212.91% | 4 | Mar 21, 2024 | |
| INCY Incyte | Reiterates: Hold | $68 | $59.02 | +15.22% | 4 | Mar 12, 2024 | |
| ABCL AbCellera Biologics | Maintains: Buy | $21 → $17 | $2.77 | +513.72% | 1 | Feb 21, 2024 | |
| EXEL Exelixis | Maintains: Hold | $23 → $25 | $22.15 | +12.87% | 8 | Feb 2, 2024 | |
| CGEN Compugen | Maintains: Buy | $3 → $4 | $1.69 | +136.69% | 1 | Dec 19, 2023 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $53 → $62 | $36.56 | +69.58% | 4 | Dec 18, 2023 | |
| IGMS IGM Biosciences | Maintains: Buy | $26 → $25 | $6.40 | +290.63% | 2 | Nov 14, 2023 | |
| HLVX HilleVax | Maintains: Buy | $35 → $30 | $14.28 | +110.08% | 2 | Nov 10, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $4 → $5 | $0.54 | +818.61% | 1 | May 17, 2023 | |
| NKTX Nkarta | Maintains: Buy | $21 → $18 | $5.26 | +242.21% | 2 | May 12, 2023 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $8.40 | +126.19% | 3 | May 9, 2023 | |
| CMPX Compass Therapeutics | Initiates: Buy | $9 | $0.88 | +922.73% | 1 | Jan 27, 2023 | |
| OABI OmniAb | Initiates: Buy | $12 | $3.67 | +226.98% | 1 | Nov 28, 2022 | |
| INO Inovio Pharmaceuticals | Downgrades: Hold | $228 → $288 | $8.43 | +3,316.37% | 4 | Jun 26, 2020 | |
| MTEM Molecular Templates | Initiates: Buy | n/a | $1.16 | - | 1 | Mar 25, 2020 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | n/a | $247.61 | - | 3 | Aug 13, 2018 | |
| IONS Ionis Pharmaceuticals | Maintains: Hold | n/a | $45.14 | - | 2 | Aug 8, 2018 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | n/a | $82.22 | - | 3 | Aug 3, 2018 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | n/a | $1.60 | - | 2 | Jul 31, 2018 | |
| INVA Innoviva | Terminates: Hold | n/a | $16.50 | - | 2 | Jun 25, 2018 | |
| GLYC GlycoMimetics | Maintains: Buy | n/a | $0.27 | - | 1 | Mar 7, 2018 | |
| ARRY Array Technologies | Maintains: Buy | n/a | $9.63 | - | 1 | Feb 7, 2018 | |
| SPRO Spero Therapeutics | Initiates: Buy | n/a | $1.31 | - | 1 | Nov 27, 2017 |
Geron
Jun 10, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $4.17
Upside: +67.87%
Insmed
Jun 5, 2024
Maintains: Buy
Price Target: $67 → $74
Current: $64.50
Upside: +14.73%
Nurix Therapeutics
May 15, 2024
Maintains: Buy
Price Target: $27
Current: $18.93
Upside: +42.63%
Bolt Biotherapeutics
May 15, 2024
Downgrades: Hold
Price Target: $6 → $1.5
Current: $0.74
Upside: +104.08%
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: $29 → $7
Current: $4.10
Upside: +70.73%
MEI Pharma
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $2.80
Upside: +150.00%
Cue Biopharma
Apr 9, 2024
Maintains: Buy
Price Target: $8
Current: $1.08
Upside: +640.74%
Vor Biopharma
Mar 21, 2024
Maintains: Buy
Price Target: $15 → $12
Current: $0.91
Upside: +1,212.91%
Incyte
Mar 12, 2024
Reiterates: Hold
Price Target: $68
Current: $59.02
Upside: +15.22%
AbCellera Biologics
Feb 21, 2024
Maintains: Buy
Price Target: $21 → $17
Current: $2.77
Upside: +513.72%
Exelixis
Feb 2, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $22.15
Upside: +12.87%
Compugen
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.69
Upside: +136.69%
Xenon Pharmaceuticals
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $36.56
Upside: +69.58%
IGM Biosciences
Nov 14, 2023
Maintains: Buy
Price Target: $26 → $25
Current: $6.40
Upside: +290.63%
HilleVax
Nov 10, 2023
Maintains: Buy
Price Target: $35 → $30
Current: $14.28
Upside: +110.08%
X4 Pharmaceuticals
May 17, 2023
Maintains: Buy
Price Target: $4 → $5
Current: $0.54
Upside: +818.61%
Nkarta
May 12, 2023
Maintains: Buy
Price Target: $21 → $18
Current: $5.26
Upside: +242.21%
Zymeworks
May 9, 2023
Maintains: Buy
Price Target: $18 → $19
Current: $8.40
Upside: +126.19%
Compass Therapeutics
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $0.88
Upside: +922.73%
OmniAb
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $3.67
Upside: +226.98%
Inovio Pharmaceuticals
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $8.43
Upside: +3,316.37%
Molecular Templates
Mar 25, 2020
Initiates: Buy
Price Target: n/a
Current: $1.16
Upside: -
Alnylam Pharmaceuticals
Aug 13, 2018
Maintains: Buy
Price Target: n/a
Current: $247.61
Upside: -
Ionis Pharmaceuticals
Aug 8, 2018
Maintains: Hold
Price Target: n/a
Current: $45.14
Upside: -
BioMarin Pharmaceutical
Aug 3, 2018
Maintains: Buy
Price Target: n/a
Current: $82.22
Upside: -
Lexicon Pharmaceuticals
Jul 31, 2018
Maintains: Buy
Price Target: n/a
Current: $1.60
Upside: -
Innoviva
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $16.50
Upside: -
GlycoMimetics
Mar 7, 2018
Maintains: Buy
Price Target: n/a
Current: $0.27
Upside: -
Array Technologies
Feb 7, 2018
Maintains: Buy
Price Target: n/a
Current: $9.63
Upside: -
Spero Therapeutics
Nov 27, 2017
Initiates: Buy
Price Target: n/a
Current: $1.31
Upside: -